Holen Sie sich die Stockscreener-App
2.185
3.07%
0.065
Schlusskurs vom Vortag:
$2.12
Offen:
$2.14
24-Stunden-Volumen:
6,807
Relative Volume:
0.32
Marktkapitalisierung:
$9.71M
Einnahmen:
$1.79M
Nettoeinkommen (Verlust:
$-64.45M
KGV:
-1.3323
EPS:
-1.64
Netto-Cashflow:
$-53.32M
1W Leistung:
-6.22%
1M Leistung:
-3.32%
6M Leistung:
-42.13%
1J Leistung:
-40.53%
1-Tages-Spanne:
$2.10
$2.2348
1-Wochen-Bereich:
$2.0799
$2.47
52-Wochen-Spanne:
$1.5201
$7.43
Senti Biosciences Inc Stock (SNTI) Company Profile
Firmenname
Senti Biosciences Inc
Sektor
Branche
Telefon
(650) 382-3281
Adresse
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Vergleichen Sie SNTI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| SNTI | 2.1599 | 9.71M | 1.79M | -64.45M | -53.32M | -1.64 |
| VRTX | 449.07 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.73 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 587.28 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.66 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.61 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
Senti Biosciences Inc Aktie (SNTI) Neueste Nachrichten
Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Senti Biosciences Faces Financial Challenges Amid Strategic Focus - TipRanks
Senti Biosciences Inc (SNTI) Quarterly 10-Q Report - Quartzy
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights - The Manila Times
Senti Bio Reports $28.9M Q3 Loss, Advances Cancer Drug Trial Amid Cost Cuts | SNTI Stock News - StockTitan
Intel says it lowered stakes in Astera Labs, Joby Aviation, Senti Biosciences - MSN
NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve
Senti Biosciences, Inc. (NASDAQ:SNTI) Short Interest Update - MarketBeat
Senti Biosciences faces nasdaq delisting over audit rule By Investing.com - Investing.com Australia
Senti Biosciences faces nasdaq delisting over audit rule - Investing.com India
Senti Biosciences (NASDAQ:SNTI) Trading 7.8% HigherHere's Why - MarketBeat
Senti Biosciences, Inc. Enters into A Sublease Agreement, or the Sublease, with BKPBIOTECH, Inc. and Jlsa2 Therapeutics, Inc - Marketscreener.com
Institutional owners may take dramatic actions as Semler Scientific, Inc.'s (NASDAQ:SMLR) recent 10% drop adds to one-year losses - Simply Wall St
Biotech Soars On Material Transfer Agreement - Invezz
Nasdaq Composite (NASX) QuotePress Release - The Globe and Mail
Sensata Technologies Holding plc (NYSE:ST) Stake Decreased by Shapiro Capital Management LLC - Defense World
Federated Hermes Inc. Increases Holdings in Sensata Technologies Holding plc (NYSE:ST) - Defense World
2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World
Granite Investment Partners LLC Increases Stock Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Moors & Cabot Inc. Acquires 8,900 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Ratios Reveal: Breaking Down SenesTech Inc (SNES)’s Financial Health - The Dwinnex
Critical Analysis: UL Solutions (NYSE:ULS) & NeoGenomics (NASDAQ:NEO) - Defense World
Daiwa Securities Group Inc. Purchases Shares of 545 Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Semler Scientific Inc (SMLR) Shares Gap Down to $24.43 on Sep 18 - GuruFocus.com
SanBio’s Q2 Financials and Regenerative Medicine Push - TipRanks
After-hours movers: Intuitive Machines, Casella Waste Systems, Galmed Pharma, Edgewise Therapeutics - Investing.com Australia
Headlands Technologies LLC Sells 3,234 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Daiwa Securities Group Inc. Has $786,000 Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Federated Hermes Inc. Raises Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - MarketBeat
SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024 - MSN
Senti Bio to Participate in Upcoming Investor Conferences - Yahoo Finance UK
Senti Biosciences (NASDAQ:SNTI) Trading Up 5.2% - MarketBeat
Biopharma Layoff Tracker 2024: Lykos, Galera, Grail and More Cut Staff - BioSpace
SNTISenti Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights - BioSpace
Intel Dumps All Of Its Shares In Arm Holdings, Still Retains Exposure To Astera Labs, Joby Aviation, MariaDB, And Senti Biosciences - Wccftech
Titan Pharmaceuticals (NASDAQ:TTNP) vs. Senti Biosciences (NASDAQ:SNTI) Critical Contrast - Defense World
A Deep Dive into Senti Biosciences Inc. (SNTI) Stock Performance - The InvestChronicle
Financial Health Report: Senti Biosciences Inc. (SNTI)’s Ratios Tell a Tale - The Dwinnex
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202 - ForexTV.com
Senti Bio announces execution of grant award from CIRM for developing SENTI-202 - TipRanks
Senti Biosciences announces 1-for-10 reverse stock split - Investing.com India
Senti Biosciences announces 1-for-10 reverse stock split By Investing.com - Investing.com Canada
Senti Biosciences Inc. (SNTI)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Senti Biosciences amends equity facility agreement - Investing.com
Senti Bio executes reverse stock split to meet Nasdaq requirements - Investing.com
Senti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance - Seeking Alpha
Senti Bio Announces Reverse Stock Split - Yahoo Finance
Senti Biosciences (NASDAQ:SNTI) Trading Down 2.1% - Defense World
Finanzdaten der Senti Biosciences Inc-Aktie (SNTI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):